(c) 2024 PillSync.com

Scytera Dailymed

  1. Human OTC
  2. Unknown Cellular or Molecular Interaction
  3. DPT Laboratories, Ltd.

Generic: coal tar foam, 2% is used for the treatment of Pityriasis Psoriasis Dermatitis, Seborrheic

Scytera aerosol, foam - image

  1. FDA Adverse Reactions

Go PRO for all pill images

Description Section

Scyteraâ„¢ Foam is an emollient foam containing 10% coal tar topical solution (Liquor Carbonis Detergens) equivalent to 2% coal tar.

Active Ingredient - Purpose

Active ingredient: Coal Tar 2% (from Coal Tar Topical Solution USP, 10%) Purpose: Psoriasis

Use

For relief of the symptoms of psoriasis.

Warnings

For external use only. Flammable Avoid fire, flame, or smoking during and immediately following application.

Do Not Use

  • for prolonged periods without consulting a doctor
  • this product in or around the rectum or in the genital area or groin except on the advice of a doctor

Ask A Doctor Before Use If You Have

a condition that covers a large area of your body.

Ask A Doctor Or Pharmacist Before Use If You Are

using the product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.

When Using This Product

  • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
  • use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application.
  • product can stain clothing, contact lenses, and hair. To minimize staining, allow product to dry before contact.

Stop Use And Ask Doctor If

condition worsens or does not improve after regular use of this product as directed.

If Pregnant Or Breastfeeding

ask a health professional before use.

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a poison control center right away.

Directions

  • shake the can well before use.
  • invert the can to dispense. Upright dispensing will cause loss of propellant.
  • apply to affected areas one to four times daily or as directed by a doctor.

Other Information

  • contents under pressure. Do not puncture or incinerate.
  • store at 68°F to 77°F (20°C to 25°C)
  • do not expose to heat or store at temperatures above 120°F (49°C)

Inactive Ingredients

Caprylic/capric triglyceride, ceteareth 20, citric acid, cyclomethicone, dimethicone, EDTA disodium, glycerin, hydroxypropyl methyl cellulose, isopropyl myristate, peppermint oil, phenoxyethanol, potassium sorbate, purified water, sodium citrate, stearic acid, xanthan gum, hydrocarbon (propane/butane) propellant. 

Questions?

1-888-966-8766

Warnings Section

WarningThis product contains chemicals known to the state of California to cause cancer. Patent PendingMade in USA. Marketed by:Promius Pharma, LLC Bridgewater, NJ 08807 Under license from Foamix LTD, Israel

Scytera (coal Tar)foam 2%, 100 G

Carton and Can Label NDC 67857-801-52Psoriasis Foam Scyteraâ„¢ (Coal Tar) Foam 2% Promius Pharma â„¢ NET WT. 3.3 oz (100 g) Carton (California) NDC 67857-801-26Psoriasis Foam Scyteraâ„¢ (Coal Tar) Foam 2% Promius Pharma â„¢ NET WT. 3.3 oz (100 g)

Scytera (coal Tar)foam 2%, 12 G Sample Size

Packer (Box) Available in 100 g Cans Scyteraâ„¢ (Coal Tar) Foam 2% Promius Pharma â„¢ Professional Samples Net Quantity 12 x 12 g Cans NDC 67857-801-12 Packer (Box) (California) Available in 100 g Cans Scyteraâ„¢ (Coal Tar) Foam 2% Promius Pharma â„¢ Professional Samples Net Quantity 12 x 12 g Cans NDC 67857-801-19 Can Label NDC 67857-801-12 Psoriasis Foam Scyteraâ„¢ (Coal Tar) Foam 2% SAMPLE, NOT FOR SALE NET WT. 0.4 oz (12 g)

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site